Keywords
Cannabidiol
Therapeutics
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To highlight new treatments for fibromyalgia and, therefore, emphasize the use of cannabis as a medicinal agent for this pathology. Methods: This work is an integrative literature review in which articles were selected from the National Library of Medicine, Virtual Health Library and EBSCOHOST databases, through the Health Sciences Descriptors: Fibromyalgia AND Cannabidiol in order to answer: In fibromyalgia therapy, can cannabinoids be considered? Results: According to the 15 final articles selected for the composition of the article, 64.3% directly characterized the use of cannabinoids for the treatment of fibromyalgia. Therefore, cannabinoids were presented as a possible treatment for pain crises, in addition to other symptoms related to the pathology. However, the use of these medications requires monitoring for better effectiveness. Final considerations: The use of cannabinoids can be a great ally for the composition of the traditional treatment of fibromyalgia, and I am able to improve the arsenal available for this treatment.
References
ALKABBANI W, et al. Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population based cohort study. Addiction, 2019; 114(10): 1791-1799.
ANAYA HJM, et al. Efficacy of cannabinoids in fibromyalgia: a literature review. Colombian Journal Of Anesthesiology, 2021; 49(4): 1-13.
BAIÃO MKV, et al. Maconha Medicinal (Cannabis sativa): usos e perspectivas clínicas. Monografia (Farmácia) - Pontifícia Universidade Católica de Goiás, Goiânia, 2021; 32 p.
BERGER AA, et al. Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia. Best Practice & Research Clinical Anaesthesiology, 2020; 34(3): 617-631.
BOEHNKE KF. et al. Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: a large online survey. The Journal Of Pain, 2021a; 22(11): 1418-1428.
BOEHNKE KF, et al. Cannabidiol Use for Fibromyalgia: prevalence of use and perceptions of effectiveness in a large online survey. The Journal Of Pain, 2021b; 22(5): 556-566.
BOEHNKE KF, et al. Cannabidiol Product Dosing and Decision-Making in a National Survey of Individuals with Fibromyalgia. The Journal Of Pain, 2022; 23(1): 45-54.
CHAVES C, et al. Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: a randomized, double-blind, placebo-controlled clinical trial. Pain Medicine, 2020; 21(10): 2212-2218.
DONK TV, et al. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. Pain, 2018; 160(4): 860-869.
ERCOLE FF, et al. Integrative review versus systematic review. Revista Mineira de Enfermagem, 2014; 18(1): 1-260.
ERGISI M, et al. An Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry. Cannabis And Cannabinoid Research, 2022; 1-10: 24.
FITZCHARLES MA, et al. Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain. Drugs, 2021; 81(18): 2103-2116.
HABIB, George et al. Medical Cannabis for the Treatment of Fibromyalgia. Jcr: Journal of Clinical Rheumatology, 2018; 24(5): 255-258.
JATOBÁ DM, et al. Alimentação como tratamento coadjuvante para pessoas com fibromialgia: uma revisão integrativa. Revista Eletrônica Acervo Saúde, 2022; 15(1): e9627.
KHURSHID H, et al. A Systematic Review of Fibromyalgia and Recent Advancements in Treatment: is medicinal cannabis a new hope? Cureus, 2021; 8(13): 1-11.
MATIAS GFS, et al. Uso de Cannabis para tratamento da dor crônica: uma revisão sistemática. Research, Society And Development, 2022; 11(3): 1-12.
MAZZA M, et al. Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series. Journal of Cannabis Research, 2021; 3(1): 1-18.
MÜCKE M, et al. Cannabis-based medicines for chronic neuropathic pain in adults. The Cochrane database of systematic reviews, 2018; 3(3): CD012182.
NIJS J, et al. Sleep disturbances and severe stress as glial activators: key targets for treating central sensitization in chronic pain patients?. Expert Opinion On Therapeutic Targets, 2017; 21(8): 817-826.
OLIVEIRA JOJ e ALMEIDA MB. The current treatment of fibromyalgia. Brazilian Journal Of Pain, 2018; 1(3): 255-262.
OLIVEIRA JOJ e RAMOS JVC. Adherence to fibromyalgia treatment: challenges and impact on the quality of life. Brazilian Journal Of Pain, 2019; 2(1): 81-87.
SARZI-PUTTINI P, et al. Medical cannabis and cannabinoids in rheumatology: where are we now?. Expert Review Of Clinical Immunology, 2019; 15(10): 1019-1032.
YASSIN M, et al. Effect of adding medical cannabis to analgesic treatment in patients with low back pain related to fibromyalgia: an observational cross-over single centre study. Clinical and experimental rheumatology, 2019; 37(Suppl 116): 13-20.